425 related articles for article (PubMed ID: 27334205)
21. Tocilizumab: a novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases.
Alten R; Maleitzke T
Ann Med; 2013 Jun; 45(4):357-63. PubMed ID: 23650978
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
Khan F; Siddiqui AA
Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
[TBL] [Abstract][Full Text] [Related]
23. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
De Jesus A; Talal N
Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
[TBL] [Abstract][Full Text] [Related]
24. [The ultrasonic assessment of heart function and pressure in the pulmonary artery of patients with rheumatic diseases].
Mit'kovskaia NP; Pimenova TN
Ter Arkh; 1992; 64(12):37-41. PubMed ID: 1292130
[No Abstract] [Full Text] [Related]
25. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases.
Mitsuo A; Morimoto S; Nakiri Y; Suzuki J; Kaneko H; Tokano Y; Tsuda H; Takasaki Y; Hashimoto H
Rheumatology (Oxford); 2006 Dec; 45(12):1477-84. PubMed ID: 16638798
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic stem cell transplantation in rheumatic diseases other than systemic sclerosis and systemic lupus erythematosus.
Tyndall A
J Rheumatol Suppl; 1997 May; 48():94-7. PubMed ID: 9150127
[TBL] [Abstract][Full Text] [Related]
27. Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases.
Denko CW; Malemud CJ
Semin Arthritis Rheum; 2005 Aug; 35(1):24-34. PubMed ID: 16084221
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of the synthesis of n-3 PUFAs in fat-1 transgenic mice inhibits mTORC1 signalling and delays surgically induced osteoarthritis in comparison with wild-type mice.
Huang MJ; Wang L; Jin DD; Zhang ZM; Chen TY; Jia CH; Wang Y; Zhen XC; Huang B; Yan B; Chen YH; Li SF; Yang JC; Dai YF; Bai XC
Ann Rheum Dis; 2014 Sep; 73(9):1719-27. PubMed ID: 23852692
[TBL] [Abstract][Full Text] [Related]
29. [Rheumatic diseases in pregnancy].
Märker-Hermann E; Bauer H; Gromnica-Ihle E
Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134
[TBL] [Abstract][Full Text] [Related]
30. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
[TBL] [Abstract][Full Text] [Related]
31. Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?
Molloy ES; Calabrese LH
Autoimmun Rev; 2008 Dec; 8(2):144-6. PubMed ID: 18700172
[TBL] [Abstract][Full Text] [Related]
32. The role of autophagy in the pathogenesis of systemic lupus erythematosus.
Liu X; Qin H; Xu J
Int Immunopharmacol; 2016 Nov; 40():351-361. PubMed ID: 27673477
[TBL] [Abstract][Full Text] [Related]
33. [Clinical study with a new phenylbutazone preparation in rheumatology].
Marmont A; Rossi F
Clin Ter; 1972 Oct; 63(1):17-51. PubMed ID: 4566104
[No Abstract] [Full Text] [Related]
34. Pulmonary pathology of the rheumatic diseases.
Leslie KO; Trahan S; Gruden J
Semin Respir Crit Care Med; 2007 Aug; 28(4):369-78. PubMed ID: 17764055
[TBL] [Abstract][Full Text] [Related]
35. [Recent progress in clinical trials for rheumatic diseases].
Tanaka Y
Nihon Rinsho; 2009 Mar; 67(3):619-25. PubMed ID: 19280942
[TBL] [Abstract][Full Text] [Related]
36. Defective autophagy in fibroblasts may contribute to fibrogenesis in autoimmune processes.
Del Principe D; Vona R; Giordani L; Straface E; Giammarioli AM
Curr Pharm Des; 2011 Dec; 17(35):3878-87. PubMed ID: 21933148
[TBL] [Abstract][Full Text] [Related]
37. [Indomethacin in rheumatic diseases with special reference to ophthalmologic studies].
Klein G; Fellner S; Fellner R
Med Klin; 1972 Feb; 67(8):250-4. PubMed ID: 4555586
[No Abstract] [Full Text] [Related]
38. Clinical significance of serum thrombomodulin levels in patients with systemic rheumatic diseases.
Kotajima L; Aotsuka S; Sato T
Clin Exp Rheumatol; 1997; 15(1):59-65. PubMed ID: 9093774
[TBL] [Abstract][Full Text] [Related]
39. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.
Wolfe F; Michaud K; Li T; Katz RS
J Rheumatol; 2010 Feb; 37(2):296-304. PubMed ID: 20032098
[TBL] [Abstract][Full Text] [Related]
40. Corticosteroids: Friends and Foes.
Bolster MB
Rheum Dis Clin North Am; 2016 Feb; 42(1):xv-xvi. PubMed ID: 26611560
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
